Neoantigens for Personalized Cancer Vaccines: Comprehensive Identification and Effective Selection
June 18, 2018 - Toronto ON CAXtalks
fbonilla@xtalks.com
Phone:4169776555
Professionals from biopharmaceutical organizations developing neoantigen-based therapeutics.
This website uses cookies to ensure you get the best experience on our website. Learn more